Get the Stockscreener App
6.34
7.17%
-0.49
After Hours:
7.30
0.96
+15.14%
Biodesix Inc stock is traded at $6.34, with a volume of 109.42K.
It is down -7.17% in the last 24 hours and down -18.09% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$6.83
Open:
$6.76
24h Volume:
109.42K
Relative Volume:
0.55
Market Cap:
$54.64M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-9.7538
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-4.66%
1M Performance:
-18.09%
6M Performance:
-38.80%
1Y Performance:
-75.62%
1-Day Range:
$6.19
$7.15
1-Week Range:
$6.19
$7.15
52-Week Range:
$3.436
$32.20
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
6.34 | 54.64M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
564.88 | 213.17B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.06 | 152.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.94 | 50.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
144.69 | 41.49B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
213.88 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Biodesix Inc (BDSX) Q3 2025 Earnings: EPS Misses, Revenue Beats Estimates with $21.8 Million - GuruFocus
Biodesix Grows On Strong Diagnostics And Raised Revenue Forecast - Finimize
Biodesix (Nasdaq: BDSX) raises 2025 revenue guidance; third-quarter revenue $21.8M - Stock Titan
Is Biodesix Inc. stock a good choice for value investorsPortfolio Update Report & Fast Momentum Stock Entry Tips - newser.com
Is Biodesix Inc. stock a defensive play in 2025M&A Rumor & Safe Capital Growth Stock Tips - newser.com
Biodesix Inc. recovery potential after sell offJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Technical signs of recovery in Biodesix Inc.Weekly Risk Summary & Free Real-Time Market Sentiment Alerts - newser.com
Regression analysis insights on Biodesix Inc. performanceJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
How to manage a losing position in Biodesix Inc.2025 Trading Recap & Free Long-Term Investment Growth Plans - newser.com
What drives Biodesix Inc stock priceQuarterly Earnings Review & Low Cost Wealth Plans - earlytimes.in
Is Bio-Rad’s Earnings Miss and Biodesix Partnership Redefining the Investment Outlook for BIO? - Yahoo Finance
Can Biodesix Inc. stock rebound after recent weaknessCPI Data & Stock Market Timing Techniques - newser.com
Can Biodesix Inc. stock outperform in 2025 bull market2025 Price Action Summary & Low Risk Entry Point Tips - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is Biodesix Inc. stock a bargain at current levelsJuly 2025 Rallies & Technical Analysis for Trade Confirmation - newser.com
How risky is Biodesix Inc. stock nowJuly 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Biodesix Inc expected to post a loss of $1.44 a shareEarnings Preview - TradingView
What To Expect From Biodesix Inc (BDSX) Q3 2025 Earnings - Yahoo Finance
Published on: 2025-10-31 06:05:51 - newser.com
Will breakout in Biodesix Inc. lead to full recoveryTrade Risk Summary & Short-Term High Return Ideas - newser.com
Is Biodesix Inc. a candidate for recovery playJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting - The Manila Times
Biodesix to Showcase R&D Innovations and Collaborations at 2025 AMP Annual Meeting in Boston - Quiver Quantitative
Biodesix (NASDAQ: BDSX) plans AMP 2025 workshop on NGS, ddPCR and mass spec advances - Stock Titan
Institutional scanner results for Biodesix Inc.July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - newser.com
Biodesix announces expanded partnership to develop Droplet Digital™ PCR High Complexity Assays - SelectScience
Order flow analysis tools used on Biodesix Inc.Forecast Cut & Growth-Oriented Investment Plans - newser.com
Biodesix CEO rings Nasdaq’s closing bell - BizWest
Louisville company rings Nasdaq bell after regaining listing compliance - The Business Journals
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.64%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):